D. Van den Weyngaert

Docetaxel, cisplatin and 5-fluorouracil in patients with locally advanced unresectable head and neck cancer: a phase I–II feasibility study

D. Schrijvers, C. van Herpen, Joseph Kerger et al. · Annals of Oncology · 2004 · 87 citations · Full text

Medicine, Oncology, Chemotherapy +8

Short-term health-related quality of life and symptom control with docetaxel, cisplatin, 5-fluorouracil and cisplatin (TPF), 5-fluorouracil (PF) for induction in unresectable locoregionally advanced head and neck cancer patients (EORTC 24971/TAX 323)

Carla M.L. van Herpen, Murielle Mauer, M. Degardin et al. · British Journal of Cancer · 2010 · 55 citations · Full text

Medicine, Oncology, Radiation Oncology +9

Palliative effectiveness of radiation therapy in the treatment of superior vena cava syndrome

An Egelmeers, C. Goor, Jan P. van Meerbeeck et al. · Bulletin du Cancer/Radiothérapie · 1996 · 37 citations

Medicine, Oncology, Surgery +8

Intensity-modulated radiotherapy in patients with head and neck cancer: a European single-centre experience

Dirk Van Gestel, D. Van den Weyngaert, D. Schrijvers et al. · British Journal of Radiology · 2011 · 32 citations

Medicine, Oncology, Radiation Oncology +12

Phase II feasibility study of concurrent radiotherapy and gemcitabine in chemonaive patients with squamous cell carcinoma of the head and neck: long-term follow up data

Pol Specenier, D. Van den Weyngaert, Carl Van Laer et al. · Annals of Oncology · 2007 · 18 citations

Medicine, Oncology, Radiation Oncology +12